202 related articles for article (PubMed ID: 4572903)
1. Immunological enhancement, blocking factors, and tolerance to tumours, transplants and foetuses.
Halliday WJ
Aust N Z J Med; 1972 Nov; 2(4):416-21. PubMed ID: 4572903
[No Abstract] [Full Text] [Related]
2. Humoral antibody in allograft reactions.
Winn HJ
Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
[No Abstract] [Full Text] [Related]
3. Transplantation immunology.
Schwartz A
Vet Clin North Am; 1974 Feb; 4(1):187-205. PubMed ID: 4274406
[No Abstract] [Full Text] [Related]
4. [Immunosuppression and enhancement].
Brendel W
Langenbecks Arch Chir; 1971 Dec; 329():742-50. PubMed ID: 4949859
[No Abstract] [Full Text] [Related]
5. The role of immunological enhancement for the growth of autochthonous tumors.
Hellström I; Hellström KE
Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
[No Abstract] [Full Text] [Related]
6. Blocking antibodies and enhancement.
Heppner GH
Ser Haematol; 1972; 5(4):41-66. PubMed ID: 4364363
[No Abstract] [Full Text] [Related]
7. [Basic general immunological phenomena in organ transplantation].
Scheiffarth F
Langenbecks Arch Chir; 1971 Dec; 329():709-16. PubMed ID: 5161712
[No Abstract] [Full Text] [Related]
8. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():301-5. PubMed ID: 4607384
[No Abstract] [Full Text] [Related]
9. A cardinal role for I-region antigens (Ia) in immunological enhancement, and the clinical implications.
Davies DA; Staines NA
Transplant Rev; 1976; 30():18-39. PubMed ID: 781923
[No Abstract] [Full Text] [Related]
10. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
Monaco AP; Wood ML
Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
[No Abstract] [Full Text] [Related]
11. The future of transplantation immunology.
Diener E; Jirsch D
Med Clin North Am; 1972 Mar; 56(2):453-64. PubMed ID: 4401651
[No Abstract] [Full Text] [Related]
12. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
Wood ML; Heppner G; Gozzo JJ; Monaco AP
Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
[No Abstract] [Full Text] [Related]
13. Tolerance and enhancement in organ transplantation.
Brent L
Transplant Proc; 1972 Sep; 4(3):363-8. PubMed ID: 4404151
[No Abstract] [Full Text] [Related]
14. Immunological enhancement of renal allografts.
Stuart FP; McKearn TJ; Fitch FW
Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
[No Abstract] [Full Text] [Related]
15. The "immunological inertia" of viviparity.
Anderson JM
Transplant Proc; 1969 Mar; 1(1):67-70. PubMed ID: 4944284
[No Abstract] [Full Text] [Related]
16. Survival of the genetically incompatible fetal allograft.
Finn R
Lancet; 1975 Apr; 1(7911):835-8. PubMed ID: 48059
[TBL] [Abstract][Full Text] [Related]
17. GVH analysis of organ-grafted rats which defy the normal rules for rejection.
Bilsoe P; Ford WL; Pettirossi O; Simonsen M
Transplantation; 1971 Sep; 12(3):189-93. PubMed ID: 4936099
[No Abstract] [Full Text] [Related]
18. Induction of immunological tolerance to allogeneic tissues in the canine species.
Rapaport FT; Watanabe K; Matsuyama M; Cannon FD; Mollen N; Blumenstock DA; Ferrebee JW
Ann Surg; 1972 Oct; 176(4):529-37. PubMed ID: 4562064
[No Abstract] [Full Text] [Related]
19. [Transplantation immunology and pregnancy].
Gulianskiĭ LN; Dukova VS
Usp Sovrem Biol; 1978; 86(2):269-82. PubMed ID: 31742
[No Abstract] [Full Text] [Related]
20. Problems and prospects in surgical immunology II.
Häyry P
Med Biol; 1976 Apr; 54(2):73-107. PubMed ID: 131887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
